The medical director of CNS clinical cevelopment at AskBio discussed long-term data presented at ATMRD from the company’s phase 1b trial assessing the investigational gene therapy AB-1005 in Parkinson disease. [WATCH TIME: 6 minutes]
Nisha Chhabria MD, FAAN
Advertisement
Medical director of CNS Clinical Development at AskBio.
Articles by Nisha Chhabria MD, FAAN
Advertisement
Latest Updated Articles
Overviewing 36-Month, Phase 1b Data Testing Gene Therapy AB-1005 in Parkinson Disease: Nisha Chhabria MD, FAANPublished: August 15th 2025 | Updated:
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
CTAD Poster Shows Etalanetug Reduced Tau Pathology Biomarkers in Dominantly Inherited Alzheimer Disease
2
Alzheimer Trial PRImus-AD Tests Orally Available PRI-002 as New Treatment
3
Early Phase 3 Data Highlight Convenience and Feasibility of Self-Administered Alzheimer Agent Remternetug
4
New Phase 2 Trial to Test TREM2-Stabilizing Agent VHB937 in Alzheimer Disease
5
